The calcitriol injection vial is used primarily to treat chronic kidney dialysis patients.
aaiPharma Inc. (AAII) today announced that Sicor Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA; TASE:TEVA), has reacquired its US marketing rights for calcitriol injection in exchange for certain payments to aaiPharma.
Additional details were not disclosed.
Calcitriol injection vial is a drug used primarily to treat chronic kidney dialysis patients with abnormally low levels of calcium in their blood.
aaiPharma Inc. is a science-based pharmaceutical company focused on pain management, with corporate headquarters in Wilmington, North Carolina.
Published by Globes [online], Israel business news - www.globes.co.il - on Thursday, December 23, 2004